UNDERWRITING AGREEMENT between TITAN PHARMACEUTICALS, INC. and as Representative of the Several Underwriters TITAN PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 12th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2018 Company Industry JurisdictionThe undersigned, Titan Pharmaceuticals, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL,...Purchase Warrant Agreement • September 12th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2018 Company Industry JurisdictionTHIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS 5 YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
TITAN PHARMACEUTICALS, INC. WARRANT AGENCY AGREEMENTWarrant Agency Agreement • September 12th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2018 Company Industry JurisdictionWARRANT AGENCY AGREEMENT (this “Warrant Agreement”) made as of _______, 2018 (the “Issuance Date”), between Titan Pharmaceuticals, Inc., a Delaware corporation, with offices at 400 Oyster Point Blvd., Suite 505, South San Francisco, California 94080 (“Company”), and Continental Stock Transfer & Trust Company, with offices at 1 State Street, 30th Floor, New York, New York 10004 (“Warrant Agent”).